GLENN ROCKMAN

Glenn Rockman serves as a Managing Partner at Adjuvant Capital, a pioneering venture capital firm dedicated to advancing global health technologies. In this pivotal role, Mr. Rockman is instrumental in shaping Adjuvant Capital's investment strategy, focusing on companies that develop innovative solutions for some of the world's most pressing health challenges. His leadership helps guide the firm's mission to invest in and nurture enterprises capable of delivering significant health impact alongside compelling financial returns.

Adjuvant Capital, under Mr. Rockman's guidance, targets investments across a spectrum of global health areas. This includes a strong emphasis on vaccines, therapeutics, diagnostics, and other health innovations designed to address infectious diseases, maternal and child health issues, and non-communicable diseases prevalent in low- and middle-income countries. The firm's unique model, supported by organizations like the Bill & Melinda Gates Foundation and the International Finance Corporation, allows it to back promising technologies that might otherwise struggle to attract traditional venture funding due to market complexities or long development timelines.

Mr. Rockman's extensive career background provides a robust foundation for his work at Adjuvant Capital. Prior to co-founding Adjuvant Capital, he held a significant position as a Director at the Bill & Melinda Gates Foundation, where he led investments in global health. This experience provided him with deep insights into the specific needs and opportunities within the global health landscape. Before his impactful tenure at the Gates Foundation, Mr. Rockman honed his financial expertise in investment banking at Goldman Sachs and in private equity. This diverse professional journey has equipped him with a unique blend of financial acumen and a profound understanding of the complexities and potential of global health innovation.

His strategic vision helps identify and support companies that are not only scientifically sound but also possess the potential for broad accessibility and affordability in the markets that need them most. Glenn Rockman's commitment to leveraging capital for positive global change underscores Adjuvant Capital's role as a vital player in the ecosystem of global health venture capital, driving progress towards a healthier, more equitable world.